Seattle Genetics (SGEN) Completes Acquisition of Cascadian Therapeutics (CASC)
March 9, 2018 9:28 AM
Seattle Genetics, Inc. (Nasdaq: SGEN) today announced it has completed its previously announced acquisition of Cascadian Therapeutics, Inc. (Nasdaq: CASC) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
